NCT03292952View on ClinicalTrials.gov

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

May 16, 2018

Study Completion Date

May 16, 2018

Conditions
ADHD
Interventions
DRUG

KP415 oral capsule

Daily dose

DRUG

Placebo oral capsule

Daily dose

Trial Locations (5)

27705

Duke University Medical Center, Durham

32751

Meridien Research, Maitland

34201

Meridien Research, Bradenton

77007

Bayou City Research, Ltd., Houston

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

Sponsors

Lead Sponsor

Zevra Therapeutics
All Listed Sponsors
lead

Zevra Therapeutics

INDUSTRY